News
Videos
Conferences
Events
Resources
Subscribe

|Videos|August 17, 2015

Antioxidant-rich Recipes for Cancer Patients

Episodes in this series

EP. 1 Obesity and Nutrition as Cancer Risk Factors

EP. 1 Obesity and Nutrition as Cancer Risk Factors

EP. 2 Navigating Supplements and Organic Foods

EP. 2 Navigating Supplements and Organic Foods

EP. 3 The Cooking Studio at JTCC

EP. 3 The Cooking Studio at JTCC

EP. 4 Appetite Stimulants and Nutritional Markers

EP. 4 Appetite Stimulants and Nutritional Markers

EP. 5 Cancer: Top Nutritional Tips

EP. 5 Cancer: Top Nutritional Tips

EP. 6 Specific Nutritional Tips for Individual Cancers

EP. 6 Specific Nutritional Tips for Individual Cancers

EP. 7 Antioxidant-rich Recipes for Cancer Patients

EP. 7 Antioxidant-rich Recipes for Cancer Patients

Image of woman, with text.

EP. 8 Emphasizing the Importance of Food Safety During Cancer Care

Newsletter

Stay up to date on cancer updates, research and education

Related Content

Biotin supplements used for cancer-related hair loss may interfere with key blood tests, risking inaccurate results and altered care decisions: © The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC – James).

Biotin Supplements May Complicate Cancer Care, Research Shows

February 2nd 2026

Dr. Brittany Dulmage explains how biotin can interfere with lab testing during cancer care: © The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC – James).

Biotin, Lab Interference and Safer Options for Cancer-Related Hair Loss

January 30th 2026

The FDA approved a larger nelarabine vial to improve dosing flexibility and simplify treatment for adult and pediatric patients with T-ALL and T-LBL: © stock.adobe.com.

FDA Approves Larger Nelarabine Vial for Some Leukemias and Lymphomas

January 29th 2026

FDA

FDA Grants Orphan Drug Status to CTD402 for Rare T-Cell Blood Cancers

January 28th 2026

As patients with advanced cancer near the end of life, reducing unnecessary medications may help prioritize comfort, quality of life, and symptom relief: © stock.adobe.com

Rethinking Medications at the End of Life for Patients With Advanced Cancer

January 27th 2026

Trending on CURE

Keytruda Combo Approved for Platinum-Resistant Ovarian Cancer

Expert Discusses FDA Approval of Chemo-Free Option for EGFR-Mutated Lung Cancer

Why Subcutaneous Darzalex Faspro Matters for Patients With Multiple Myeloma

MRD Testing May Offer Peace of Mind to Breast Cancer Survivors

FDA Clears PD-L1 Test to Guide Keytruda Use in Ovarian Cancer